1993
DOI: 10.1073/pnas.90.11.5199
|View full text |Cite
|
Sign up to set email alerts
|

"Caged" phenylephrine: development and application to probe the mechanism of alpha-receptor-mediated vasoconstriction.

Abstract: A "caged" analogue of the a-adrenergic receptor agonist phenylephrine (PE) was prepared by exploiting the 2-nitrobenzyl protecting group and using a synthetic procedure developed to permit preferential derivatization at the amino group. On isolated adult rat mesenteric arterioles, caged-PE had no measurable effects at concentrations up to 100 IAM; 0.5-ms light flashes in the presence of caged-PE, however, produced marked and dose-dependent vasoconstriction. Flashinduced vasoconstrictions were blocked by the a-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
18
0

Year Published

1995
1995
2020
2020

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 21 publications
(22 reference statements)
0
18
0
Order By: Relevance
“…A long lag phase between the binding of an excitatory agonist to its receptor and contraction is a characteristic property of smooth muscle, evident even when diffusional delays are eliminated through photolysis of caged agonists (Somlyo et al, 1988a;Muralidharan et al, 1993;Walker et al, 1993). A major component of the delay (1-2 s in guinea pig portal vein smooth muscle stimulated with phenylephrine at room temperature; Somlyo et al (1988a)) is due to phospholipase C-mediated generation of inositol 1,4,5-trisphosphate that is the messenger of pharmacomechanical Ca 2Ļ© release from the sarcoplasmic reticulum (reviewed by Somlyo and Somlyo (1990)).…”
mentioning
confidence: 99%
“…A long lag phase between the binding of an excitatory agonist to its receptor and contraction is a characteristic property of smooth muscle, evident even when diffusional delays are eliminated through photolysis of caged agonists (Somlyo et al, 1988a;Muralidharan et al, 1993;Walker et al, 1993). A major component of the delay (1-2 s in guinea pig portal vein smooth muscle stimulated with phenylephrine at room temperature; Somlyo et al (1988a)) is due to phospholipase C-mediated generation of inositol 1,4,5-trisphosphate that is the messenger of pharmacomechanical Ca 2Ļ© release from the sarcoplasmic reticulum (reviewed by Somlyo and Somlyo (1990)).…”
mentioning
confidence: 99%
“…[20] The increasing in Ca 2+ concentration can be induced by Ca 2+ influx through voltage-dependent Ca 2+ channels or intracellular Ca 2+ release. The resulting effect is an increase in intracellular Ca 2+ concentration and the activation of IP3 signal transduction pathway, respectively.…”
Section: Vasorelaxant Activitymentioning
confidence: 99%
“…Another approach was the synthesis and characterisation of bioreversible phenylephrone derivatives [42]. The preparation of a "caged" phenylephrine as a product of selective derivatization on the amine function was an approach to probe the mechanism of ā£ receptor mediated vasoconstriction in isolated adult rat mesenteric arterioles [43].…”
Section: Irradiation Experimentsmentioning
confidence: 99%